Vismodegib Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 150mg
Reference Brands: ERIVEDGE (USA/EU)
Category: Oncology Cancer Care
Vismodegib is an oral small-molecule inhibitor of the Hedgehog signaling pathway, specifically targeting the Smoothened (SMO) receptor. It is used in the treatment of adults with metastatic or locally advanced basal cell carcinoma that cannot be treated with surgery or radiation. By blocking abnormal cell signaling, Vismodegib helps slow or stop the growth of cancerous cells. Erivedge is taken orally once daily and is among the first targeted therapies developed for advanced skin cancer. Vismodegib is available in Capsules and strengths such as 150mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vismodegib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Vismodegib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Vismodegib is used to treat adults with metastatic or locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation. It works by inhibiting the Hedgehog signaling pathway, which is involved in the growth and development of certain cancers, thereby slowing or stopping tumor progression.
Vismodegib is made from Vismodegib, a small-molecule Hedgehog pathway inhibitor that specifically targets and blocks the Smoothened (SMO) receptor involved in cancer cell signaling.
The trade name of Vismodegib is Erivedge.
Vismodegib (Erivedge) is developed and manufactured by Genentech, a member of the Roche Group, and marketed globally under approved regulatory pathways.
The generic name of Vismodegib is Vismodegib.
The brand name of Vismodegib is Erivedge.
Vismodegib is manufactured in the United States and Switzerland by Genentech and Roche under strict GMP-certified facilities for oncology therapeutics.
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
